fda warning bpc-157 compounded peptide FDA's Overreach on Peptides fda bpc-157 compounding safety risks

[30:07] Andrew Huberman How much relative cost, 150 versus 1500

The idea is to translate this into a new manufactured islet cell therapy approach that would also modify a persons immune cells so that immunosuppression is not required

Lysenko AV, Uskova NI

While individual variation exists, complete absence of any effect at 4mg or higher suggests a calculation issue or a peptide potency problem

While N-Acetyl Selank Amidate is expected to have similar effects with potentially greater magnitude thanks to its enhanced pharmacokinetics, there is no data to confirm this, save for anecdotal reports

Hsieh et al., Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation, J